BioCentury
ARTICLE | Company News

Alexion SBC-103 news

March 10, 2017 7:39 PM UTC

Alexion said it will "reduce its investment" in SBC-103 (rhNAGLU). The company said that in 4Q16 it recognized an $85 million impairment charge related to SBC-103. Alexion said no additional trials ar...